Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781935 · ClinicalTrials.gov registry record
Diffusion-Weighted MRI for Liver Metastasis
A clinical trial, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- Completed
- Registry status
- 233
- Enrollment target
NCT02781935 is a clinical trial that has completed, run by European Organisation for Research and Treatment of Cancer - EORTC. The registered enrollment target is 233 participants.
The verdict
NCT02781935 has completed, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- COMPLETED
- Registry status
- 233 participants
- Enrollment target
Study Summary
The DREAM study will assess the diagnostic accuracy of diffusion-weighted MRI in combination with other imaging modalities (multiparametric MRI and CT Scan) in determining the true status of disappearing liver metastasis (DLM) detected after conversion systemic therapy for unresectable or borderline resectable colorectal liver metastasis (CRLM).
Interventions
- PROCEDURE DW-MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2016-11 |
| Est. Completion | 2023-09-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02781935
The ClinicalTrials.gov registry entry for NCT02781935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DW-MRI is the first listed.
NCT02781935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02781935 about?
NCT02781935 is a clinical study titled "Diffusion-Weighted MRI for Liver Metastasis". The DREAM study will assess the diagnostic accuracy of diffusion-weighted MRI in combination with other imaging modalities (multiparametric MRI and CT Scan) in determining the true status of disappearing liver metastasis (DLM) detected after conversion systemic therapy for unresectable or borderline...
What is the current status of trial NCT02781935?
This trial is currently completed. The enrollment target is 233 participants. The study started on 2016-11. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT02781935?
The interventions under investigation include: DW-MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02781935?
This trial is sponsored by European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.